Health-related quality of life as an outcome variable in Parkinson’s disease
Authors:
- Pablo Martinez-MartinPMPablo Martinez-Martin
- Mónica M. KurtisMKMónica M. Kurtis
- 16 December 2011
- journal article
- review article
- Published by SAGE Publications in Therapeutic Advances in Neurological Disorders
- Vol. 5 (2) , 105-117
Abstract
In the past three decades, health-related quality of life (HRQoL) has become an outcome variable in Parkinson’s disease clinical trials. This review considers the measuring tools that have been developed, suitability of data reporting, complexity of outcome interpretation, and clinical application to provide evidence regarding available therapeutic interventions to date. In the introduction, different terms regarding quality of life are clearly defined. The methodology section offers an overview of generic, disease specific, and recommended HRQoL scales in Parkinson’s disease and the most important psychometric attributes a scale should meet. The interpretation of HRQoL outcomes is complex and not intuitive. Thus, appropriate reporting of data is crucial in order to calculate relative change, a result that facilitates understanding to what extent an intervention is beneficial. The concept of minimally important change/difference is explained as well as the different approaches to its calculation (anchor-based and distribution-based methods). In the results section, a brief overview of the impact on HRQoL of currently available treatments in Parkinson’s disease is provided. Special emphasis is given to data assessment, highlighting reports that helped understanding of the clinical significance of the intervention and therefore aided in making therapeutic decisions. The discussion section emphasizes the need for more clinical trials with HRQoL as a primary outcome and standardized reporting in order to further our understanding of the complexity of treatment effects and make evidence-based clinical decisions regarding HRQoL in patients with Parkinson’s disease.Keywords
This publication has 100 references indexed in Scilit:
- Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trialThe Lancet Neurology, 2010
- Greater improvement in quality of life following unilateral deep brain stimulation surgery in the globus pallidus as compared to the subthalamic nucleusJournal of Neurology, 2009
- Triangulating Patient and Clinician Perspectives on Clinically Important Differences in Health‐Related Quality of Life among Patients with Heart DiseaseHealth Services Research, 2007
- A randomised controlled trial of a home based exercise programme to reduce the risk of falling among people with Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Incorporating the Patient's Perspective into Drug Development and Communication: An Ad Hoc Task Force Report of the Patient-Reported Outcomes (PRO) Harmonization Group Meeting at the Food and Drug Administration, February 16, 2001Value in Health, 2003
- The development and validation of a short measure of functioning and well being for individuals with Parkinson's diseaseQuality of Life Research, 1995
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- Interpreting changes in quality-of-life score in N of 1 randomized trialsControlled Clinical Trials, 1991
- Measurement of health statusControlled Clinical Trials, 1989
- The Nottingham health profile: Subjective health status and medical consultationsSocial Science & Medicine. Part A: Medical Psychology & Medical Sociology, 1981